Endoscopy 2009; 41(12): 1062-1068
DOI: 10.1055/s-0029-1215331
Original article

© Georg Thieme Verlag KG Stuttgart · New York

Transgastric biologic mesh delivery and abdominal wall hernia repair in a porcine model

E.  Sporn1 , J.  A.  Astudillo1 , S.  L.  Bachman1 , T.  P.  Mayfield1 , K.  Thaler1 , B.  W.  Miedema1
  • 1Department of Surgery, University of Missouri, Columbia, Missouri, USA
Further Information

Publication History

submitted 11 March 2009

accepted after revision 17 August 2009

Publication Date:
04 December 2009 (online)

Preview

Background and study aims: Incisional abdominal wall hernias currently require repair with open or laparoscopic surgery, which is associated with wound complications and recurrent hernia formation. Natural orifice transluminal endoscopic surgery (NOTES) techniques may have the potential to decrease the morbidity associated with hernia repair. The aim of this study was to repair a chronic ventral hernia with a biologic mesh placed transgastrically in a porcine model.

Materials and methods: Six pigs underwent creation of an incisional abdominal wall hernia. At least 4 weeks later, transgastric repair was done using an underlay biologic mesh with at least 5 cm of overlap from the hernia fascial edge. The mesh was secured with transfascial sutures and the stomach was closed with a sutured gastropexy. Pigs were evaluated 2 weeks later by laparoscopy. Pigs were sacrificed and necropsy wa s performed 4 weeks after the repair.

Results: Six pigs underwent hernia repair lasting a mean (± SD) of 204 ± 123 minutes, with one perioperative death. At 2 weeks after hernia repair, laparoscopy showed significant adhesions in all pigs; one pig had extensive mesh infection and was sacrificed. Necropsy on one pig at 2 weeks and four pigs at 4 weeks showed complete coverage of the hernia defect in all pigs. All pigs had mesh abscesses or a positive mesh culture.

Conclusion: Transgastric repair of a chronic ventral hernia is technically feasible. Difficulties with mesh delivery and infection need to be overcome before this approach can be used in humans.

B. W. MiedemaMD 

Department of Surgery
University of Missouri

One Hospital Drive
MC520 McHaney Hall
Columbia
MO 65212
USA

Fax: +1-573-884-5049

Email: miedemab@health.missouri.edu